Trinity Resources, Inc. engages in the exploration and development of natural resource interests. The company is headquartered in Henderson, Nevada. The company went IPO on 2001-07-11. The firm is engaged in research and development targeting treatments of brain diseases. The company is also focused on chemical development of its new drugs dedicated to the symptomatic treatment of Alzheimer’s Disease but can be applied to other neurological diseases due to its platform technology.
Alzex Neuropharma Inc'in kazanç kalite puanı B+/53.83151'dir. Puan, karlılık, büyüme, nakit üretimi ve sermaye tahsisi ile kaldıraç olmak üzere dört boyuta dayanır.
Alzex Neuropharma Inc kazançlarını ne zaman rapor eder?
Alzex Neuropharma Inc'in bir sonraki kazanç raporu 'te bekleniyor